CHIARUGI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 15.448
EU - Europa 11.557
AS - Asia 6.133
SA - Sud America 864
AF - Africa 187
OC - Oceania 94
Continente sconosciuto - Info sul continente non disponibili 4
Totale 34.287
Nazione #
US - Stati Uniti d'America 15.171
PL - Polonia 3.879
RU - Federazione Russa 2.963
SG - Singapore 1.927
IT - Italia 1.502
CN - Cina 1.327
HK - Hong Kong 997
BR - Brasile 673
VN - Vietnam 660
SE - Svezia 655
IE - Irlanda 650
KR - Corea 471
DE - Germania 434
FR - Francia 306
FI - Finlandia 297
UA - Ucraina 291
GB - Regno Unito 289
CA - Canada 206
IN - India 205
AU - Australia 91
ID - Indonesia 90
NL - Olanda 80
AR - Argentina 75
BD - Bangladesh 75
TR - Turchia 72
JO - Giordania 69
ES - Italia 57
JP - Giappone 51
CH - Svizzera 50
CI - Costa d'Avorio 39
MX - Messico 37
EC - Ecuador 32
ZA - Sudafrica 31
BE - Belgio 29
IQ - Iraq 28
MA - Marocco 23
CL - Cile 20
CO - Colombia 19
NG - Nigeria 19
VE - Venezuela 18
PK - Pakistan 17
SC - Seychelles 17
MY - Malesia 16
PH - Filippine 16
EG - Egitto 15
TH - Thailandia 15
AE - Emirati Arabi Uniti 12
AT - Austria 12
AL - Albania 11
PY - Paraguay 11
SA - Arabia Saudita 11
UZ - Uzbekistan 11
DK - Danimarca 9
DZ - Algeria 9
NP - Nepal 9
PE - Perù 9
TN - Tunisia 9
KE - Kenya 8
AZ - Azerbaigian 7
CR - Costa Rica 7
SN - Senegal 7
CZ - Repubblica Ceca 6
JM - Giamaica 6
LT - Lituania 6
PA - Panama 6
PT - Portogallo 6
TW - Taiwan 6
BO - Bolivia 5
GR - Grecia 5
IR - Iran 4
RO - Romania 4
BG - Bulgaria 3
BJ - Benin 3
CY - Cipro 3
DO - Repubblica Dominicana 3
EU - Europa 3
GE - Georgia 3
GT - Guatemala 3
HR - Croazia 3
KG - Kirghizistan 3
KH - Cambogia 3
KW - Kuwait 3
KZ - Kazakistan 3
LB - Libano 3
LV - Lettonia 3
MM - Myanmar 3
NI - Nicaragua 3
OM - Oman 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
IL - Israele 2
MD - Moldavia 2
QA - Qatar 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
ET - Etiopia 1
GA - Gabon 1
Totale 34.270
Città #
Warsaw 3.874
Santa Clara 2.280
Ashburn 1.969
Fairfield 1.621
Singapore 1.396
Hong Kong 846
Woodbridge 699
Chandler 683
Dublin 650
Seattle 645
Houston 620
Cambridge 611
San Jose 545
Wilmington 505
Seoul 430
Jacksonville 416
Florence 334
Beijing 315
Ann Arbor 274
Altamura 241
Lawrence 234
Buffalo 213
Ho Chi Minh City 204
Princeton 188
Hefei 185
Lauterbourg 166
Los Angeles 156
Munich 154
Council Bluffs 153
The Dalles 146
Mcallen 145
Montréal 135
Boston 127
Boardman 126
Moscow 121
Hanoi 120
Dallas 117
Mumbai 108
Helsinki 102
Medford 89
Melbourne 88
Dong Ket 86
New York 81
San Diego 79
Shanghai 75
São Paulo 72
Milan 71
Jakarta 69
Paris 57
Kent 55
Tokyo 45
Bern 44
Guangzhou 41
Phoenix 41
Turku 41
Rome 40
Abidjan 39
Frankfurt am Main 38
Izmir 38
Norwalk 36
Orem 35
Clifton 34
Falls Church 30
Pune 29
Brussels 28
London 28
Redondo Beach 28
Auburn Hills 27
Barcelona 27
Bremen 27
Haiphong 27
Rio de Janeiro 27
Naples 26
Brooklyn 24
Da Nang 23
Toronto 23
Seongnam 22
Andover 21
Dearborn 21
Hillsboro 21
Montreal 20
Tianjin 20
Chennai 19
Frankfurt Am Main 19
Abuja 18
Bologna 17
Washington 17
San Francisco 16
Chicago 15
Denver 15
Hải Dương 15
Belo Horizonte 14
Yubileyny 14
Amman 13
Ankara 13
Baghdad 13
Curitiba 13
Johannesburg 13
Manchester 13
Redmond 13
Totale 23.917
Nome #
HIF-1α stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells. 920
RUOLO DELL’INTERAZIONE TRA FIBROBLASTI STROMALI E CELLULE DI CARCINOMA PROSTATICO NELL’ACQUISIZIONE DI UN FENOTIPO METASTATICO. 794
Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts. 358
Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells. 329
Etoposide-Bevacizumab a new strategy against human melanoma cells expressing stem-like traits 328
Cancer associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness. 324
Time-dependent stabilization of hypoxia inducible factor-1α by different intracellular sources of reactive oxygen species. 316
Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer 311
EphrinA1 repulsive response is regulated by an EphA2 tyrosine phosphatase 307
Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation. 303
The role of M1 and M2 macrophages in prostate cancer in relation to extracapsular tumor extension and biochemical recurrence after radical prostatectomy 302
ROLE OF STROMAL FIBROBLASTS INTERACTION WITH PROSTATIC CANCER CELLS IN ACHIEVEMENT OF METASTATIC PHENOTYPE. 297
The effects of CA IX catalysis products within tumor microenvironment 287
"β3-Adrenoreceptors Control Mitochondrial Dormancy in Melanoma and Embryonic Stem Cells, 287
Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells 284
Redox regulation of ephrin/integrin cross-talk 278
Role of stromal fibroblasts interaction with prostatic cancer cells in achievement of metastatic phenotype. 278
Globular adiponectin activates motility and regenerative traits of muscle satellite cells. 278
Rac and Rho GTPases in cancer cell motility control. 276
Redox Regulation of Nonmuscle Myosin Heavy Chain during Integrin Engagement. 275
In vivo inactivation of phosphotyrosine protein phosphatases by nitric oxide. 274
The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival 271
Oxidative stress, tumor microenvironment, and metabolic reprogramming: a diabolic liaison. 265
Escaping from, moving towards, following a path, squeezing through: lots of opportunities for moving cells. 263
Bone marrow-derived mesenchymal stem cells promote invasiveness and transendothelial migration of osteosarcoma cells via a mesenchymal to amoeboid transition 261
Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and prostate cancer metastatic spread 259
The role of Cys-17 in the pyridoxal 5'-phosphate inhibition of the bovine liver low M(r) phosphotyrosine protein phosphatase. 258
Reactive oxygen species: friends and foes of signal transduction. 254
Glucose Metabolic Reprogramming of ER Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib 249
5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like trait 246
Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer 246
Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transfer 245
Anoikis: an emerging hallmark in health and diseases. 244
Cancer stemness and progression: Mitochondria on the stage 244
c-Src activates both STAT1 and STAT3 in PDGF-stimulated NIH3T3 cells. 239
QUANTITATIVE ANALYSIS OF LACTOYLGLUTATHIONE: A NEW 2D-HPLC-MS/MS APPROACH WITHOUT ION-PAIR AGENTS 235
Aspartic-129 is an essential residue in the catalytic mechanism of the low M(r) phosphotyrosine protein phosphatase 235
Lipoyl-Homotaurine Derivative (ADM_12) Reverts Oxaliplatin-Induced Neuropathy and Reduces Cancer Cells Malignancy by Inhibiting Carbonic Anhydrase IX (CAIX) 233
Norepinephrine promotes tumor microenvironment reactivity through β3-adrenoreceptors during melanoma progression. 232
β3-adrenoreceptor and tumor microenvironment: a new hub 231
Mesenchymal Stem Cells are Recruited and Activated into Carcinoma-Associated Fibroblasts by Prostate Cancer Microenvironment-Derived TGF-β1 229
The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style. 221
Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts 221
Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression. 214
Lactate modulates CD4 + T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8/miR21 axis 212
Down-Regulation of SOX2 Underlies the Inhibitory Effects of the Triphenylmethane Gentian Violet on Melanoma Cell Self-Renewal and Survival 211
Stromal-induced mitochondrial re-education: Impact on epithelial-to-mesenchymal transition and cancer aggressiveness. 207
Cloning and expression of the cDNA coding for the erythrocyte isoenzyme of human acylphosphatase. 206
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis 206
Multiwalled carbon nanotubes for drug delivery: Efficiency related to length and incubation time 203
The ”click-on-tube” approach for the production of efficient drug carriers based on oxidize multiwalled carbon nanotubes 203
miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors. 203
Chronic Resveratrol Treatment Ameliorates Cell Adhesion and Mitigates the Inflammatory Phenotype in Senescent Human Fibroblasts 202
Inhibitory effect of full-length human endostatin on in vitro angiogenesis. 202
A novel redox-based switch: LMW-PTP oxidation enhances Grb2 binding and leads to ERK activation. 201
Stromal-induced downregulation of miR-1247 promotes prostate cancer malignancy 201
β3-adrenoceptor as a potential immuno-suppressor agent in melanoma 199
Anoikis molecular pathways and its role in cancer progression. 197
Treatment with Cannabinoids as a Promising Approach for Impairing Fibroblast Activation and Prostate Cancer Progression 192
Characterization of a novel nucleolytic activity of acylphosphatases 192
Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors 192
EphA2 reexpression prompts invasion of melanoma cells shifting from mesenchymal to amoeboid-like motility style 191
Conjugation of a GM3 lactone mimetic on carbon nanotubes enhances the related inhibition of melanoma-associated metastatic events 190
Down-regulation of platelet-derived growth factor receptor signaling during myogenesis. 189
Anoikis: A necessary death program for anchorage-dependent cells. 188
Microenvironment and tumor cell plasticity: An easy way out. 187
Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells 187
Zoledronic Acid Inhibits the RhoA-mediated Amoeboid Motility of Prostate Cancer Cells. 187
Senescent stroma promotes prostate cancer progression: The role of miR-210 186
22 : 6n-3 DHA inhibits differentiation of prostate fibroblasts into myofibroblasts and tumorigenesis. 185
Lactate supports cell-autonomous ECM production to sustain metastatic behavior in prostate cancer 184
An in vitro molecular study of Nicotiana tabacum L. genome in the presence or absence of the herbicide atrazine. 184
Acylphosphatase is involved in differentiation of K562 cells 184
LMW-PTP is a negative regulator of insulin-mediated mitotic and metabolic signalling 184
Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. 184
SHMT2-mediated mitochondrial serine metabolism drives 5-FU resistance by fueling nucleotide biosynthesis 183
Beta-catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherin-mediated cell-cell adhesion increase. 183
Stromal fibroblasts synergize with hypoxic oxidative stress to enhance melanoma aggressiveness. 181
Anchorage-dependent cell growth: tyrosine kinases and phosphatases meet redox regulation. 179
Differential role of four cysteines on the activity of a low Mr phosphotyrosine protein phosphatase 179
INSULIN INHIBITS PLATELET-DERIVED GROWTH FACTOR-INDUCED CELL PROLIFERATION 179
Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER+ breast cancer 178
Lactate in Sarcoma Microenvironment: Much More than just a Waste Product. 177
miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer. 177
Inhibition of MMPs supports amoeboid angiogenesis hampering VEGF-targeted therapies via MLC and ERK 1/2 signaling 176
Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma 176
Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation. 173
LMW-PTP is a positive regulator of tumor onset and growth 172
Low molecular weight protein-tyrosine phosphatase is involved in growth inhibition during cell differentiation. 171
Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a CTGF(CCN2)/TGF-beta-dependent mesechymal-to mesenchymal transition 171
Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression 169
Integrin-mediated cell adhesion and spreading engage different sources of reactive oxygen species. 168
Differential migration of acylphosphatase isoenzymes from cytoplasm to nucleus during apoptotic cell death. 168
Nutritional and metabolic signalling through GPCRs 166
Mitochondrial Redox Hubs as Promising Targets for Anticancer Therapy 166
Angiopoietin like 7, a novel pro-angiogenetic factor over-expressed in cancer 164
Lactate: A Metabolic Driver in the Tumour Landscape 164
FADS1/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancer 163
Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target. 163
Lymphocyte function-associated antigen-1-mediated T cell adhesion is impaired by low molecular weight phosphotyrosine phosphatase-dependent inhibition of FAK activity 163
Totale 23.349
Categoria #
all - tutte 88.712
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.712


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021345 0 0 0 0 0 0 0 0 0 0 136 209
2021/20221.437 56 176 111 44 60 58 73 90 70 82 249 368
2022/20233.323 306 655 161 248 245 574 385 192 360 20 93 84
2023/20241.347 46 133 208 83 85 191 61 315 35 50 77 63
2024/20257.760 273 850 485 1.281 2.074 854 112 582 406 222 342 279
2025/20268.742 1.055 1.204 697 820 1.234 389 1.267 468 647 650 311 0
Totale 34.579